Australia In Vitro Fertilization Market Size & Outlook
Related Markets
Australia in vitro fertilization market highlights
- The Australia in vitro fertilization market generated a revenue of USD 652.4 million in 2023 and is expected to reach USD 1,050.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 7% from 2024 to 2030.
- In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2023.
- Frozen Nondonor is the most lucrative procedure type segment registering the fastest growth during the forecast period.
In vitro fertilization market data book summary
Market revenue in 2023 | USD 652.4 million |
Market revenue in 2030 | USD 1,050.9 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
Other key industry trends
- In terms of revenue, Australia accounted for 2.6% of the global in vitro fertilization market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan in vitro fertilization market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,815.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vitro Fertilization Market Scope
In Vitro Fertilization Market Companies
Name | Profile | # Employees | HQ | Website |
---|---|---|---|---|
US Fertility | View profile | 1001-5000 | Rockville, Maryland, United States, North America | https://www.usfertility.com/ |
TFP Fertility Group | View profile | 501-1000 | Oxford, Oxfordshire, United Kingdom, Europe | https://tfp-fertility.com/ |
RMA Network | View profile | 101-250 | Basking Ridge, New Jersey, United States, North America | https://rmanetwork.com/ |
Fortis Healthcare | View profile | 10001+ | Gurgaon, Haryana, India, Asia | http://fortishealthcare.com |
Nova IVF | View profile | 11-50 | Mountain View, California, United States, North America | https://www.novaivf.com |
Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | http://www.cookmedical.com |
Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
Genea Biomedx | View profile | 101-250 | Sydney, New South Wales, Australia, Oceania | https://www.geneabiomedx.com |
The Cooper Companies Inc | View profile | 15000 | 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 | https://www.coopercos.com |
Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
Vitrolife AB ADR | View profile | 1116 | Box 9080, Gothenburg, Sweden, 400 92 | https://www.vitrolife.com |
Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Australia in vitro fertilization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.05% in 2023. Horizon Databook has segmented the Australia in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
The fertility services market in Australia is expected to witness substantial growth in the forecast period due to several factors. These include an increase in infertility cases, a trend of delayed pregnancies among women, advancements in fertility procedures, and numerous fertility clinics with skilled medical professionals.
The availability of advanced fertility treatments, a rise in disposable income, and favorable reimbursement policies contribute to the market's expansion in Australia. Recent innovations in ART and improvements in success rates are also projected to drive the demand for fertility services in the future.
However, the higher cost associated with fertility services may pose a challenge to the market's growth. Furthermore, key players focusing on new launches in the country are expected to boost the growth of the market.
Reasons to subscribe to Australia in vitro fertilization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia in vitro fertilization market databook
-
Our clientele includes a mix of in vitro fertilization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Australia in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia in vitro fertilization market size, by procedure type, 2018-2030 (US$M)
Australia In Vitro Fertilization Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more